Comparison of Two Oxygenation Targets With Two Different Oximeters - Impact on Oxygen Flow Rates and Oxygenation
Launched by LAVAL UNIVERSITY · Oct 18, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of oxygen monitors (called oximeters) affect the amount of oxygen needed for patients who have had heart surgery and are recovering in the intensive care unit. The researchers want to see how well these oximeters measure oxygen levels in the blood and how that might change the amount of oxygen patients receive. They found that some oximeters are better at detecting low oxygen levels, while others may give inaccurate readings, which can lead to different amounts of oxygen being prescribed.
To be eligible for this study, participants need to be at least 18 years old, currently in the cardiac surgery intensive care unit, and receiving oxygen therapy through a nasal cannula. They should also have a specific level of oxygen in their blood. Participants will not be allowed to join if they have certain conditions or are using other types of breathing support. Those who participate can expect to help improve understanding of how to provide better oxygen care for patients in similar situations. It's important to note that most of the participants in this study will have light skin, which may affect the results.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥ 18 years of age
- • Patients admitted to postoperative cardiac surgery intensive care unit
- • Presence of an arterial catheter Specific for the extubate patient
- • Ongoing on conventional oxygen therapy at moderate flow (up to a maximum of 5L/min) with SpO2 between 88 and 100% with the usual oximeter and nasal cannula.
- • SpO2 \< 92% ambient air Specific for the intubate patient FiO2 \<= 0.60 with SpO2 between 88 and 100% with usual oximeter SpO2 \< 92% with FiO2 0.21
- Exclusion Criteria:
- • No SpO2 signal with oximeter in use
- • False nails or nail polish
- • Methemoglobinemia \>0.015 on last available arterial gas
- • Patient in isolation (multi-resistant bacteria, C-Difficile, SARS-CoV-2 ...) Specific for the extubate patient
- • Expected to use another respiratory support within one hour of inclusion (NIV or nasal high flow oxygen) Planned extubation within one hour of inclusion
About Laval University
Laval University is a prestigious research institution located in Quebec, Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. The university actively engages in clinical trials aimed at exploring new therapeutic interventions and improving patient outcomes. With a strong emphasis on ethical standards and rigorous scientific methodologies, Laval University collaborates with multidisciplinary teams of researchers, healthcare professionals, and industry partners to conduct high-quality clinical research. Its state-of-the-art facilities and dedication to fostering a culture of inquiry position Laval University as a leader in clinical research, contributing significantly to the understanding and treatment of diverse medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Quebec, , Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials